Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Kingwood, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Houston Heart & Vascular Associates
mi
from
Kingwood, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Sugar Land, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Acacia Medical Research Institute, LLC
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Sugar Land, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Health Plus Clinical Research
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Waco, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Hillcrest Family Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Burke, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Burke Internal Medicine And Research
mi
from
Burke, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Falls Church, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Seven Corners Medical Research Center
mi
from
Falls Church, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Port Orchard, WA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Frandsen Family Medicine DBA Sound Medi
mi
from
Port Orchard, WA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
North Vancouver,
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The Medical Arts Health Research Group
mi
from
North Vancouver,
Click here to add this to my saved trials
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Status: Enrolling
Updated:  4/3/2018
mi
from
Phoenix, AZ
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Status: Enrolling
Updated: 4/3/2018
Carl T. Hayden VA Medical Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Dietary Lipid Induced Insulin Resistance
Mechanisms of Dietary Lipid Induced Insulin Resistance
Status: Enrolling
Updated:  4/3/2018
mi
from
Phoenix, AZ
Dietary Lipid Induced Insulin Resistance
Mechanisms of Dietary Lipid Induced Insulin Resistance
Status: Enrolling
Updated: 4/3/2018
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption
Controlled Feeding Study to Show Effects of Manipulating Carbohydrate and Cheese on Health Markers In Individuals With Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
mi
from
Columbus, OH
Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption
Controlled Feeding Study to Show Effects of Manipulating Carbohydrate and Cheese on Health Markers In Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Physical Activity and Education Services - PAES
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Function of Hormones Present In Taste Buds
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated:  4/4/2018
mi
from
Baltimore, MD
A Study of the Function of Hormones Present In Taste Buds
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Albuminuria HIV-Infected Patients
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Evaluation of Albuminuria HIV-Infected Patients
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Albuminuria HIV-Infected Patients
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated:  4/4/2018
mi
from
Washington,
Evaluation of Albuminuria HIV-Infected Patients
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Study of Molecular Pathways in Medullary Thyroid Carcinoma (MTC) and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Study of Molecular Pathways in Medullary Thyroid Carcinoma (MTC) and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Status: Enrolling
Updated: 4/4/2018
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated:  4/9/2018
mi
from
San Diego, CA
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated:  4/9/2018
mi
from
Chicago, IL
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated:  4/9/2018
mi
from
Boston, MA
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Massachusetts General Hospital, Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated:  4/9/2018
mi
from
Columbus, OH
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated:  4/9/2018
mi
from
Houston, TX
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Status: Enrolling
Updated:  4/10/2018
mi
from
San Antonio, TX
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Status: Enrolling
Updated: 4/10/2018
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
Comparison of Sleep-wake LH Frequency in Peripubertal Girls With and Without Hyperandrogenemia
Status: Enrolling
Updated:  4/11/2018
mi
from
Charlottesville, VA
Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
Comparison of Sleep-wake LH Frequency in Peripubertal Girls With and Without Hyperandrogenemia
Status: Enrolling
Updated: 4/11/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Hypogonadism in Young Men With Type 2 Diabetes
Effect of Hypogonadotropic Hypogonadism and Replacement With Clomiphene Citrate and Testosterone on Insulin Sensitivity, Body Composition, Inflammation, Sexual Function and Spermatogenesis in Young Type 2 Diabetic Men
Status: Enrolling
Updated:  4/17/2018
mi
from
Buffalo, NY
Hypogonadism in Young Men With Type 2 Diabetes
Effect of Hypogonadotropic Hypogonadism and Replacement With Clomiphene Citrate and Testosterone on Insulin Sensitivity, Body Composition, Inflammation, Sexual Function and Spermatogenesis in Young Type 2 Diabetic Men
Status: Enrolling
Updated: 4/17/2018
Millard Fillmore Gates Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated:  4/17/2018
mi
from
Bronx, NY
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated: 4/17/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Status: Enrolling
Updated:  4/17/2018
mi
from
Boston, MA
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Status: Enrolling
Updated: 4/17/2018
MGH Diabetes Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Mobile Phone-based Program for Adults With Prediabetes
A Mixed Methods Pilot Randomized Controlled Trial of a Mobile Phone-based Health Program Among Adults With Prediabetes
Status: Enrolling
Updated:  4/18/2018
mi
from
Ann Arbor, MI
A Mobile Phone-based Program for Adults With Prediabetes
A Mixed Methods Pilot Randomized Controlled Trial of a Mobile Phone-based Health Program Among Adults With Prediabetes
Status: Enrolling
Updated: 4/18/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated:  4/19/2018
mi
from
Bronx, NY
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Status: Enrolling
Updated:  4/19/2018
mi
from
Bronx, NY
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Status: Enrolling
Updated: 4/19/2018
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated:  4/19/2018
mi
from
Birmingham, AL
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated: 4/19/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Status: Enrolling
Updated:  4/27/2018
mi
from
Rochester, MN
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Status: Enrolling
Updated: 4/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated:  4/30/2018
mi
from
Chula Vista, CA
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated: 4/30/2018
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials